3rd APACC 2018 – Presentations

 

Thursday - 28/06/2018

 

Professor David Cooper Tribute Eulogy
Praphan Phanuphak, MD, PhD
Thai Red Cross AIDS Research Centre, Thailand

 

Boyd, Mark 2015

Mark Boyd, MD, FRACP
Lyell McEwin Hospital, University of Adelaide, Australia

 
  Plenairy session 1: Strategies to end AIDS in the Asia-Pacific 
Chairs: Annette Sohn & Patrick Chung-Ki Li
 
 David Cooper Memorial Lecture: Current effort to control
the epidemic in the region

Nittaya Phanuphak, MD, PhD
Thai Red Cross AIDS Research Centre, Thailand
 
 WHO’s regional strategies
Polin Chan, MD
World Health Organization
 
  Parallel session 1: Future of ART in LMICs 
Chairs: Mark Boyd & Shui Shan Lee
 
 IP and regulatory barriers to access ART and drugs for
co-infections in LMICs

Leena Menghaney
Médecins Sans Frontières (MSF), India
 
 Treatment regimens for the public health approach –
do we need to change?

Nicholas Paton, MD, FRCP
National University of Singapore, Singapore
 
  Parallel session 2: Evolving epidemiology 
Chairs: Charles Boucher & Hongzhou Lu
 
 Derivation of population mixing patterns from virus sequence data and
their impacts on the modelling of HIV epidemics in MSM

Ngai Sze Wong
 #1
 Transmitted drug resistance and impact on long-term clinical outcomes
in the VMVN clinical trial in Hanoi, Vietnam

Thuy Le
 #2
 Treatment outcome and drug resistance mutations among patients on
LPVr-containing second-line antiretroviral therapy in Vietnam
(Not available)

Junko Tanuma
 #3
 Chemsex: prevalence, characteristics and associated risk profiles of men
who have sex with men in South Australia: a cross-sectional cohort study

Carole Khaw
 #4
 

Friday- 29/06/2018

 Planairy session 2: Management of advanced HIV disease 
Chairs: Thuy Le & Chien-Ching Hung
 
 Current gaps between policy and practice
in the Asia Pacific region

Nagalingesawaran Kumarasamy, MD, PhD
YRGCARE Medical Centre, VHS, Chennai, India
 
 Challenges in the management of advanced HIV disease from the clinical perspective
Linghua Li, MD, PhD
Guanghzou Eighth People’s Hospital, China
 
 Public health approach to reduce the burden of advanced HIV disease
Polin Chan, MD
World Health Organization
 
  Parallel session 3: Social media and mHealth 
Chairs: Joseph Tucker & Julia Sun
 
 Social media to increase HIV testing uptake in China
Weiming Tang, PhD, MS, MD
Dermatology Hospital of Southern Medical University, China
 
 Systematic review of social media HIV interventions
Bolin Cao, PhD
Shenzhen University, China
 
 Social media platforms for LGBT inclusion
Laurindo Garcia
B-Change Group, the Philippines and Singapore
 
  Parallel session 4: Co-infections and complications 
Chairs: Edsel Salvana & Shinichi Oka
 
 Human papillomavirus prevalence and behavioral risk factors among
HIV-Infected men in central Taiwan

Yuan-Ti Lee
 #5
 Malignancies in adults living with HIV in Asia
(Not available)

Awachana Jiamsakul
 #6
 Drivers for mental health issues among young and old HIVinfected individuals and opportunities for intervention
Reena Rajasuriar
 #7
 Asymptomatic talaromyces mareffei infection is associated with HIV mortality
(Not yet available)
Thu Nguyen Thi Mai
 #8
 Outcome of HCV treatment by direct acting antiretroviral (DAAs) among
HCV/HIV co-infections in Vietnam

Thu Nguyen
 #9
  Parallel session 5: Poster discussion on MSM and TG sexual risk in Asia 
Chairs: Joseph Tucker & Nittaya Phanuphak
 
 Identifying MSM-competent physicians in China: A national online
cross-sectional survey among physicians who see male HIV/STD patients

Peipei Zhao
 #57
 Pre-exposure prophylaxis (PrEP) service in a South East Asian
university hospital – one year experience

Dariusz Piotr Olszyna
 #66
 Treatment for anorectal Chlamydia trachomatis infection with
azithromycin 1g single dose in mem who have sex with men w/o HIV infection
Daisuke Mizushima
 #69
 Reducing condomless sex among Chinese Men Who Have Sex with Men
through repeated exposure to online videos: results from an online cohort study

Wenting Huang
 #81
 The pattern of risk compensation in MSM enrolled in a pilot PrEP project
Tsz Ho Kwan
 #82
 Voices of the hidden: Implementation of the people living with
HIV stigma index in Taiwan

Yi-Chi Chiu
 #91
  Parallel session 6: Poster discussion on strategies to improve HIV outcomes in Asia 
Chairs: Thuy Le & Nagalingesawaran Kumarasamy
 
 Cost-effectiveness of Dolutegravir in HIV-1 treatment-naïve patients in China
Yogesh Punekar
 #19
 DTG versus LPV/r in second line (DAWNING): outcomes
by WHO-recommended NRTI backbone
Yinzhong Shen
 #34
 Assessing the efficacy of Lopinavir /ritonavir based preferred and alternative second-line regimens on HIV-infected patients : a meta-analysis as a key evidence support for WHO recommendations
Yaokai Chen
 #35
 Routine versus targeted viral load strategy among patients starting ART in Hanoi, Vietnam
Todd Pollack
 #51
 Replicating the success: Using an HIV model of peer driven intervention (PDI+) to increase TB new case detection in Cambodia
Kolab Chhim
 #64
 Optimal timing of antiretroviral therapy for HIV-infected patients with cryptococcal meningitis: A systematic review and meta-analysis
Yaokai Chen
 #74
  Parallel session 7: Optimizing clinical management of long-term complications 
Chairs: Jonathan Schapiro & Grace Lui
 
 Improving tolerability by optimizing ART
Kiat Ruxrungtham, MD
Chulalongkorn University, HIV-NAT, Thailand
 
 Addressing long-term complications to improve health outcomes
in HIV

Reena Rajasuriar, MPharm, PhD
University of Malaya, Malaysia
 
  Parallel session 8: Prevention and linkage to treatment 
Chairs: Praphan Phanuphak & Michael Cassell
 
 Feasibility and outcome of rapid initiation of antiretroviral treatment among newly-diagnosed HIV-positive patients at a tertiary center in Taiwan
Yi-Chia Huang
 #10
 Impact of initiation of combination antiretroviral therapy according to
the WHO recommendations on the survival of HIV-positive patients in Taiwan

Wang-Da Liu
 #11
 Renal and liver function changes among post-exposure prophylaxis clients
at the Thai Red Cross Anonymous Clinic in Bangkok

Samanan Thongyoi
 #12
 Changes in creatinine and estimated glomerular filtration rate during the first 12-month period of pre-exposure prophylaxis among PrEP-30 clients at the Thai Red Cross anonymous clinic
Piyanuch Tuntikul
 #13
 Debate: IPT should be implemented for all HIV patients in the Asia-Pacific 
Chairs: Annette Sohn
 
 

Pro debater: IPT should be implemented for all HIV patients
in the Asia-Pacific

Mark Boyd, MD, FRACP
Lyell McEwin Hospital, University of Adelaide, Australia

 

Le, Thuy_2015_120Con debater: IPT should be implemented for all HIV patientsin the Asia-Pacific
Thuy Le , MD, DPhil
The Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, the Hospital for Tropical Diseases, Vietnam

 
 

Friday- 30/06/2018

  Parallel session 9: Panel discussion: Key populations-led health service models 
Chairs: Nittaya Phanuphak & Jeremy Ross
 
 Cassell, Michael_2017 120Why we need KPLHS to end AIDS in the Asia Pacific
Michael Cassell, PhD, MEM, MA
FHI 360, Thailand
 
 Phaengnongyang,Chamrong 2018 120x160KPLHS for same-day ART and differentiated service delivery in Thailand
Chamrong Phaengnongyang
Service Workers in Group Foundation, Thailand
 
 KPLHS for HIV testing and PrEP in Vietnam
(Not yet available)

Kimberly Green, MA, PhD
PATH, Vietnam
 
  Airawanwat,Rangsima_2018_120x160Sustainability of KPLHS through capacity building platform
Rangsima Airawanwat, PhD
Thai Red Cross AIDS Research Centre, Thailand
 
  Parallel session 10: Immune interventions to control HIV 
Chairs: Daniel Kuritzkes
 
 Introduction to immunology - What clinicians need to know
Paul Cameron, BMedSci, MBBS, PhD, FRACP, FRCPA
University of Melbourne, Australia
 
 Broadly neutralizing antibodies for treatment and prevention of HIV-1
Daniel Kuritzkes, MD
Harvard Medical School, USA
 
  Plenairy session 3: Viral Hepatitis 
Chairs: Owen Tsang & Evy Yunihastuti
 
 What’s new in Hepatitis B treatment & diagnostics
(Not available)

Seng Gee Lim, MBBS, FRACP, FRCP, MD
National University of Singapore, Singapore
 
 Hep C: How we are going to get to hep C elimination
from a clinician’s perspective

Gail Matthews, MBCHB, MRCP (UK), FRACP, PhD
The Kirby Institute, UNSW, Australia
 
 Hep C: Country experience with elimination efforts
Vithurneat Hang, PhD
Medecins Sans Frontieres (MSF), Cambodia
 
 Capacity building sessions 
 
 

How to do a systematic review
Matthew Law, BA (Hons), MSc, PhD
The Kirby Institute, Australia

 

Tucker, Joseph 2017 120x160
Joseph Tucker, MD, PhD, AM
University of North Carolina Chapel Hill, USA

 
 

Research methodology
Matthew Law, BA (Hons), MSc, PhD
The Kirby Institute, Australia

 

Boyd, Mark 2015
Mark Boyd, MD, FRACP
Lyell McEwin Hospital, University of Adelaide, Australia

 
 

Getting involved in clinical research: from clinical trials
to sub-studies

Nicholas Paton, MD, FRCP
National University of Singapore, Singapore

Le, Thuy_2015_120
Thuy Le, MD, DPhil
Oxford University Clinical Research Unit, the Hospital for Tropical Diseases, Vietnam